Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07453225) titled 'Empirical Radioactive Iodine Therapy in DTC' on Feb. 25.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Assiut University

Condition: Differentiated Thyroid Cancer

Intervention: Drug: Radioactive Iodine Therapy

Recruitment Status: Not recruiting

Phase: Phase 1/Phase 2

Date of First Enrollment: April 1, 2026

Target Sample Size: 100

To know more, visit https://clinicaltrials.gov/study/NCT07453225

Published by HT Digi...